Mobile

A study to evaluate the long term safety of rhuMab Beta7 in patients with moderate to severe ulcerative colitis (a form of inflammatory bowel disease) Estudio para evaluar la seguridad de rhuMab...

Update Il y a 4 ans
Reference: EUCTR2011-003409-36

A study to evaluate the long term safety of rhuMab Beta7 in patients with moderate to severe ulcerative colitis (a form of inflammatory bowel disease) Estudio para evaluar la seguridad de rhuMab Beta7 a largo plazo en pacientes con colitis ulcerosa moderada o grave (una forma de enfermedad inflamatoria del intestino)

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To assess the long-term safety and tolerability of rhuMAb Beta7, as measured by adverse events, immunogenicity and safety laboratory parameters, over an extended 2 year treatment period Evaluar la seguridad y la tolerabilidad a largo plazo de rhuMAb Beta7, en base a acontecimientos adversos, inmunogenicidad y parámetros de seguridad de laboratorio durante un período de tratamiento ampliado de 2 años

Inclusion criteria

  • Ulcerative colitis,Colitis Ulcerosa

Links